Dianthus Therapeutics, Inc.

NASDAQ:DNTH

Biotechnology

Healthcare
$84.83 -1.25%

-$1.03 today

Market cap
$4.78B
Beta
0.07
P/E (TTM)
-343.0
EPS (TTM)
-$0.24
52W Low $16.64High $96.50

Volume 0.89M

Average 0.82M

Fair Value & DCF

Compare our fair value with your own assumptions

Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.

Dianthus Therapeutics, Inc.

NASDAQ:DNTH

Intrinsic Alpha fair value

Locked

Current Price

$84.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.

Build your own valuation

Test an independent scenario and compare it with Intrinsic Alpha's estimate.

Sign in to use the DCF calculator

Free accounts get 5 valuations per week. Upgrade for more.

Sign in / Sign up

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A5 analysts
RevenueN/AN/A-31.8%
+219.0% (5yr)12 analysts
Net IncomeN/AN/AN/A
N/A12 analysts
EBITN/AN/AN/A
N/A12 analysts

Analysis

Recent growth has been strongest in Revenue at -31.8% over three years. Forward estimates point to Revenue at +219.0% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Estimates & History

Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.

Further estimates hidden. Sign in to unlock

Competitor Valuations

Peer stocks ranked by intrinsic value status

CompanyMarket CapPriceValuationP/E1Y Return

Immunovant, Inc.

NASDAQ:IMVT

$7.07B$34.18Not rated-14.3+42.69%

Vera Therapeutics, Inc.

NASDAQ:VERA

$2.03B$28.10Not rated-6.8-4.02%

AnaptysBio, Inc.

NASDAQ:ANAB

$1.38B$46.25Overvalued-59.7+88.77%

MoonLake Immunotherapeutics

NASDAQ:MLTX

$1.06B$12.50Not rated-5.4-15.15%

Alumis Inc. Common Stock

NASDAQ:ALMS

$724.84M$5.60Not rated-12.2-37.43%

Q32 Bio Inc.

NASDAQ:QTTB

$260.64M$8.71Not rated5.4+339.38%

Artiva Biotherapeutics, Inc.

NASDAQ:ARTV

$198.22M$4.01Not rated-2.7+20.82%

Cartesian Therapeutics, Inc.

NASDAQ:RNAC

$193.69M$6.35Not rated-1.7-17.62%

Connect Biopharma Holdings Limited

NASDAQ:CNTB

$42.65M$0.68Not rated-4.0-74.53%